| Year |
Citation |
Score |
| 2018 |
Timur AA, Barnard J, Murugesan G, Gandhi S, Bhatt DL, Kottke-Marchant K. The relation between ABO blood types and clinical and platelet function parameters in patients who underwent percutaneous coronary intervention. Coronary Artery Disease. PMID 30407210 DOI: 10.1097/Mca.0000000000000676 |
0.334 |
|
| 2016 |
Bastijanic JM, Kligman FL, Marchant RE, Kottke-Marchant K. Dual biofunctional polymer modifications to address endothelialization and smooth muscle cell integration of ePTFE vascular grafts. Journal of Biomedical Materials Research. Part A. 104: 71-81. PMID 26177606 DOI: 10.1002/Jbm.A.35541 |
0.596 |
|
| 2015 |
Bastijanic JM, Marchant RE, Kligman F, Allemang MT, Lakin RO, Kendrick D, Kashyap VS, Kottke-Marchant K. First in vivo evaluation of biomimetic fluorosurfactant polymer-coated expanded polytetrafluoroethylene vascular grafts in a porcine carotid artery bypass model. Journal of Vascular Surgery. PMID 25827964 DOI: 10.1016/J.Jvs.2015.01.060 |
0.605 |
|
| 2015 |
Jones DR, Marchant RE, von Recum H, Sen Gupta A, Kottke-Marchant K. Photoinitiator-free synthesis of endothelial cell-adhesive and enzymatically degradable hydrogels. Acta Biomaterialia. 13: 52-60. PMID 25462848 DOI: 10.1016/J.Actbio.2014.11.012 |
0.616 |
|
| 2014 |
Lin L, Marchant RE, Zhu J, Kottke-Marchant K. Extracellular matrix-mimetic poly(ethylene glycol) hydrogels engineered to regulate smooth muscle cell proliferation in 3-D. Acta Biomaterialia. 10: 5106-15. PMID 25173839 DOI: 10.1016/J.Actbio.2014.08.025 |
0.595 |
|
| 2014 |
Timur AA, Murugesan G, Zhang L, Barnard J, Bhatt DL, Kottke-Marchant K. Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy. Thrombosis Research. 134: 96-104. PMID 24852729 DOI: 10.1016/J.Thromres.2014.04.023 |
0.336 |
|
| 2014 |
Dudash LA, Kligman FL, Bastijanic JM, Kottke-Marchant K, Marchant RE. Cross-reactivity of cell-selective CRRETAWAC peptide with human and porcine endothelial cells. Journal of Biomedical Materials Research. Part A. 102: 2857-63. PMID 24123752 DOI: 10.1002/Jbm.A.34960 |
0.632 |
|
| 2014 |
Lin L, Zhu J, Kottke-Marchant K, Marchant RE. Biomimetic-engineered poly (ethylene glycol) hydrogel for smooth muscle cell migration. Tissue Engineering. Part A. 20: 864-73. PMID 24093717 DOI: 10.1089/Ten.Tea.2013.0050 |
0.613 |
|
| 2012 |
Dudash LA, Kligman F, Sarett SM, Kottke-Marchant K, Marchant RE. Endothelial cell attachment and shear response on biomimetic polymer-coated vascular grafts. Journal of Biomedical Materials Research. Part A. 100: 2204-10. PMID 22623267 DOI: 10.1002/Jbm.A.34119 |
0.603 |
|
| 2012 |
Timur AA, Murugesan G, Zhang L, Aung PP, Barnard J, Wang QK, Gaussem P, Silverstein RL, Bhatt DL, Kottke-Marchant K. P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. International Journal of Laboratory Hematology. 34: 473-83. PMID 22574824 DOI: 10.1111/J.1751-553X.2012.01420.X |
0.322 |
|
| 2012 |
Depta JP, Kottke-Marchant K, Bhatt DL. Response to Letter Regarding Article “Clinical Outcomes Using a Platelet Function-Guided Approach for Secondary Prevention in Patients With Ischemic Stroke or Transient Ischemic Attack” Stroke. 43. DOI: 10.1161/Strokeaha.112.673210 |
0.308 |
|
| 2011 |
Liew YP, Fissell R, Bhatt DL, Kottke-Marchant K, Heyka RJ. Accuracy and reliability of point-of-care platelet assays in hemodialysis patients Interventional Cardiology. 3: 515-520. DOI: 10.2217/Ica.11.51 |
0.336 |
|
| 2010 |
Beamish JA, He P, Kottke-Marchant K, Marchant RE. Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Engineering. Part B, Reviews. 16: 467-91. PMID 20334504 DOI: 10.1089/Ten.Teb.2009.0630 |
0.547 |
|
| 2010 |
Beamish JA, Zhu J, Kottke-Marchant K, Marchant RE. The effects of monoacrylated poly(ethylene glycol) on the properties of poly(ethylene glycol) diacrylate hydrogels used for tissue engineering. Journal of Biomedical Materials Research. Part A. 92: 441-50. PMID 19191313 DOI: 10.1002/Jbm.A.32353 |
0.575 |
|
| 2009 |
Beamish JA, Geyer LC, Haq-Siddiqi NA, Kottke-Marchant K, Marchant RE. The effects of heparin releasing hydrogels on vascular smooth muscle cell phenotype. Biomaterials. 30: 6286-94. PMID 19709740 DOI: 10.1016/J.Biomaterials.2009.08.004 |
0.579 |
|
| 2009 |
Beamish JA, Fu AY, Choi AJ, Haq NA, Kottke-Marchant K, Marchant RE. The influence of RGD-bearing hydrogels on the re-expression of contractile vascular smooth muscle cell phenotype. Biomaterials. 30: 4127-35. PMID 19481795 DOI: 10.1016/J.Biomaterials.2009.04.038 |
0.576 |
|
| 2009 |
Kottke-Marchant K. Importance of platelets and platelet response in acute coronary syndromes. Cleveland Clinic Journal of Medicine. 76: S2-7. PMID 19332590 DOI: 10.3949/Ccjm.76.S1.01 |
0.368 |
|
| 2009 |
Wang S, Gupta AS, Sagnella S, Barendt PM, Kottke-Marchant K, Marchant RE. Biomimetic fluorocarbon surfactant polymers reduce platelet adhesion on PTFE/ePTFE surfaces. Journal of Biomaterials Science. Polymer Edition. 20: 619-35. PMID 19323880 DOI: 10.1163/156856209X426439 |
0.769 |
|
| 2009 |
Zhu J, Tang C, Kottke-Marchant K, Marchant RE. Design and synthesis of biomimetic hydrogel scaffolds with controlled organization of cyclic RGD peptides. Bioconjugate Chemistry. 20: 333-9. PMID 19191566 DOI: 10.1021/Bc800441V |
0.609 |
|
| 2009 |
Tang C, Kligman F, Larsen CC, Kottke-Marchant K, Marchant RE. Platelet and endothelial adhesion on fluorosurfactant polymers designed for vascular graft modification. Journal of Biomedical Materials Research. Part A. 88: 348-58. PMID 18286624 DOI: 10.1002/Jbm.A.31888 |
0.665 |
|
| 2008 |
Huang G, Zhou Z, Srinivasan R, Penn MS, Kottke-Marchant K, Marchant RE, Gupta AS. Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets. Biomaterials. 29: 1676-85. PMID 18192005 DOI: 10.1016/J.Biomaterials.2007.12.015 |
0.626 |
|
| 2008 |
Christie DJ, Kottke-Marchant K, Gorman RT. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy. Platelets. 19: 104-10. PMID 17852773 DOI: 10.1080/09537100701504095 |
0.316 |
|
| 2007 |
Larsen CC, Kligman F, Tang C, Kottke-Marchant K, Marchant RE. A biomimetic peptide fluorosurfactant polymer for endothelialization of ePTFE with limited platelet adhesion. Biomaterials. 28: 3537-48. PMID 17507089 DOI: 10.1016/J.Biomaterials.2007.04.026 |
0.642 |
|
| 2006 |
Larsen CC, Kligman F, Kottke-Marchant K, Marchant RE. The effect of RGD fluorosurfactant polymer modification of ePTFE on endothelial cell adhesion, growth, and function. Biomaterials. 27: 4846-55. PMID 16762410 DOI: 10.1016/J.Biomaterials.2006.05.009 |
0.638 |
|
| 2006 |
Karha J, Rajagopal V, Kottke-Marchant K, Bhatt DL. Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers. American Heart Journal. 151: 976.e7-11. PMID 16644316 DOI: 10.1016/J.Ahj.2006.02.017 |
0.359 |
|
| 2006 |
Gupta AS, Wang S, Link E, Anderson EH, Hofmann C, Lewandowski J, Kottke-Marchant K, Marchant RE. Glycocalyx-mimetic dextran-modified poly(vinyl amine) surfactant coating reduces platelet adhesion on medical-grade polycarbonate surface. Biomaterials. 27: 3084-95. PMID 16460796 DOI: 10.1016/J.Biomaterials.2006.01.002 |
0.616 |
|
| 2006 |
Zhu J, Beamish JA, Tang C, Kottke-Marchant K, Marchant RE. Extracellular matrix-like cell-adhesive hydrogels from RGD-containing poly(ethylene glycol) diacrylate Macromolecules. 39: 1305-1307. DOI: 10.1021/Ma052333S |
0.619 |
|
| 2005 |
Sagnella S, Anderson E, Sanabria N, Marchant RE, Kottke-Marchant K. Human endothelial cell interaction with biomimetic surfactant polymers containing Peptide ligands from the heparin binding domain of fibronectin. Tissue Engineering. 11: 226-36. PMID 15738677 DOI: 10.1089/Ten.2005.11.226 |
0.774 |
|
| 2005 |
Gupta AS, Huang G, Lestini BJ, Sagnella S, Kottke-Marchant K, Marchant RE. RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system. Thrombosis and Haemostasis. 93: 106-14. PMID 15630499 DOI: 10.1160/Th04-06-0340 |
0.761 |
|
| 2004 |
Anderson EH, Ruegsegger MA, Murugesan G, Kottke-Marchant K, Marchant RE. Extracellular matrix-like surfactant polymers containing arginine-glycine-aspartic acid (RGD) peptides. Macromolecular Bioscience. 4: 766-75. PMID 15468270 DOI: 10.1002/Mabi.200300125 |
0.608 |
|
| 2004 |
Sagnella SM, Kligman F, Anderson EH, King JE, Murugesan G, Marchant RE, Kottke-Marchant K. Human microvascular endothelial cell growth and migration on biomimetic surfactant polymers. Biomaterials. 25: 1249-59. PMID 14643599 DOI: 10.1016/S0142-9612(03)00634-3 |
0.764 |
|
| 2004 |
Zidar FJ, Moliterno DJ, Bhatt DL, Kottke-Marchant K, Goormastic M, Plow EF, Topol EJ. 1100-59 High-dose clopidogrel loading rapidly reduces both platelet inflammatory marker expression and aggregation Journal of the American College of Cardiology. 43. DOI: 10.1016/S0735-1097(04)90269-0 |
0.307 |
|
| 2003 |
Sagnella S, Kligman F, Marchant RE, Kottke-Marchant K. Biometric surfactant polymers designed for shear-stable endothelialization on biomaterials. Journal of Biomedical Materials Research. Part A. 67: 689-701. PMID 14674370 DOI: 10.1002/Jbm.A.10035 |
0.768 |
|
| 2003 |
Cho L, Kottke-Marchant K, Lincoff AM, Roffi M, Reginelli JP, Kaldus T, Moliterno DJ. Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations. The American Journal of Cardiology. 91: 1110-3. PMID 12714157 DOI: 10.1016/S0002-9149(03)00159-0 |
0.31 |
|
| 2002 |
Murugesan G, Ruegsegger MA, Kligman F, Marchant RE, Kottke-Marchant K. Integrin-dependent interaction of human vascular endothelial cells on biomimetic peptide surfactant polymers. Cell Communication & Adhesion. 9: 59-73. PMID 12487408 DOI: 10.1080/15419060214148 |
0.627 |
|
| 2002 |
Kottke-Marchant K, Bahit MC, Granger CB, Zoldhelyi P, Ardissino D, Brooks L, Griffin JH, Potthoff RF, Van De Werf F, Califf RM, Topol EJ. Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes: The GUSTO-IIb haemostasis substudy European Heart Journal. 23: 1202-1212. PMID 12127922 DOI: 10.1053/Euhj.2001.3074 |
0.369 |
|
| 2002 |
Wheeler GL, Braden GA, Steinhubl SR, Kereiakes DJ, Kottke-Marchant K, Michelson AD, Furman MI, Mueller MN, Moliterno DJ, Sane DC. The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy. American Heart Journal. 143: 602-11. PMID 11923796 DOI: 10.1067/Mhj.2002.121734 |
0.333 |
|
| 2002 |
Kottke-Marchant K, Corcoran G. The laboratory diagnosis of platelet disorders. Archives of Pathology & Laboratory Medicine. 126: 133-46. PMID 11825107 DOI: 10.1043/0003-9985(2002)126<0133:Tldopd>2.0.Co;2 |
0.31 |
|
| 2002 |
Lestini BJ, Sagnella SM, Xu Z, Shive MS, Richter NJ, Jayaseharan J, Case AJ, Kottke-Marchant K, Anderson JM, Marchant RE. Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 78: 235-47. PMID 11772464 DOI: 10.1016/S0168-3659(01)00505-3 |
0.742 |
|
| 2002 |
Sanborn SL, Murugesan G, Marchant RE, Kottke-Marchant K. Endothelial cell formation of focal adhesions on hydrophilic plasma polymers. Biomaterials. 23: 1-8. PMID 11762827 DOI: 10.1016/S0142-9612(01)00066-7 |
0.592 |
|
| 2001 |
Sagnella S, Kwok J, Marchant RE, Kottke-Marchant K. Shear-induced platelet activation and adhesion on human pulmonary artery endothelial cells seeded onto hydrophilic polymers Journal of Biomedical Materials Research. 57: 419-431. PMID 11523037 DOI: 10.1002/1097-4636(20011205)57:3<419::Aid-Jbm1185>3.0.Co;2-I |
0.77 |
|
| 2001 |
Gum PA, Kottke-Marchant K, Poggio ED, Gurm H, Welsh PA, Brooks L, Sapp SK, Topol EJ. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. The American Journal of Cardiology. 88: 230-5. PMID 11472699 DOI: 10.1016/S0002-9149(01)01631-9 |
0.309 |
|
| 2001 |
Kottke-Marchant K, Sapatnekar S. Hemostatic Abnormalities in Cardiopulmonary Bypass: Pathophysiologic and Transfusion Considerations Seminars in Cardiothoracic and Vascular Anesthesia. 5: 187-206. DOI: 10.1053/Scva.2001.26125 |
0.336 |
|
| 2000 |
Raghavachari M, Tsai H, Kottke-Marchant K, Marchant RE. Surface dependent structures of von Willebrand factor observed by AFM under aqueous conditions. Colloids and Surfaces. B, Biointerfaces. 19: 315-324. PMID 11064254 DOI: 10.1016/S0927-7765(00)00140-5 |
0.58 |
|
| 2000 |
Raghavachari M, Kottke-Marchant K, Marchant RE. Determining intramolecular binding sites on surface-bound von Willebrand factor under aqueous conditions. Thrombosis Research. 98: 351-8. PMID 10822082 DOI: 10.1016/S0049-3848(00)00185-7 |
0.549 |
|
| 1999 |
Kottke-Marchant K, Powers JB, Brooks L, Kundu S, Christie DJ. The effect of antiplatelet drugs, heparin, and preanalytical variables on platelet function detected by the platelet function analyzer (PFA-100®) Clinical and Applied Thrombosis/Hemostasis. 5: 122-130. PMID 10725993 DOI: 10.1177/107602969900500209 |
0.373 |
|
| 1999 |
Siedlecki CA, Wang IW, Higashi JM, Kottke-Marchant K, Marchant RE. Platelet-derived microparticles on synthetic surfaces observed by atomic force microscopy and fluorescence microscopy Biomaterials. 20: 1521-1529. PMID 10458565 DOI: 10.1016/S0142-9612(99)00065-4 |
0.606 |
|
| 1998 |
Brieger DB, Mak KH, Kottke-Marchant K, Topol EJ. Heparin-induced thrombocytopenia. Journal of the American College of Cardiology. 31: 1449-59. PMID 9626819 DOI: 10.1016/S0735-1097(98)00134-X |
0.321 |
|
| 1998 |
Mak K, Brooks L, Topol E, Kottke-Marchant K. In Vitro Efficacy of Platelet Glycoprotein IIb/IIIa Antagonist in Blocking Platelet Function in Plasma of Patients with Heparin-induced Thrombocytopenia Thrombosis and Haemostasis. 80: 989-993. DOI: 10.1055/S-0037-1615399 |
0.38 |
|
| 1997 |
Simpfendorfer C, Kottke-Marchant K, Lowrie M, Anders RJ, Burns DM, Miller DP, Cove CS, DeFranco AC, Ellis SG, Moliterno DJ, Raymond RE, Sutton JM, Topol EJ. First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions. Circulation. 96: 76-81. PMID 9236420 DOI: 10.1161/01.Cir.96.1.76 |
0.34 |
|
| 1997 |
Insler SR, Kraenzler EJ, Bartholomew JR, Kottke-Marchant K, Lytle B, Starr NJ. Thrombosis during the use of the heparinoid organon 10172 in a patient with heparin-induced thrombocytopenia Anesthesiology. 86: 495-498. PMID 9054269 DOI: 10.1097/00000542-199702000-00026 |
0.34 |
|
| 1996 |
Kottke-Marchant K, Veenstra AA, Marchant RE. Human endothelial cell growth and coagulant function varies with respect to interfacial properties of polymeric substrates Journal of Biomedical Materials Research. 30: 209-220. PMID 9019486 DOI: 10.1002/(Sici)1097-4636(199602)30:2<209::Aid-Jbm11>3.0.Co;2-H |
0.619 |
|
| 1996 |
Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood. 88: 2939-50. PMID 8874190 DOI: 10.1182/Blood.V88.8.2939.Bloodjournal8882939 |
0.548 |
|
| 1996 |
Gottlieb A, Tabares AH, Levy P, Sprung J, Kottke-Marchant K, Schoenwald PK. Use of Low Molecular Weight Heparin in Patients with Heparin-induced Thrombocytopenia Undergoing Carotid Endarterectomy Anesthesiology. 85: 678-681. PMID 8853099 DOI: 10.1097/00000542-199609000-00028 |
0.349 |
|
| 1996 |
Muehrcke DD, McCarthy PM, Kottke-Marchant K, Harasaki H, Pierre-Yared J, Borsh JA, Ogella DA, Cosgrove DM. Biocompatibility of heparin-coated extracorporeal bypass circuits: A randomized, masked clinical trial The Journal of Thoracic and Cardiovascular Surgery. 112: 472-483. PMID 8751516 DOI: 10.1016/S0022-5223(96)70275-1 |
0.331 |
|
| 1996 |
Yuan S, Cai W, Szakalas-Gratzl G, Kottke-Marchant K, Tweden K, Marchant RE. Immobilization of heparin oligosaccharides onto radiofrequency plasma modified pyrolytic carbon-coated graphite. Journal of Applied Biomaterials : An Official Journal of the Society For Biomaterials. 6: 259-66. PMID 8589511 DOI: 10.1002/Jab.770060407 |
0.603 |
|
| 1996 |
Mak K, Kottke-Marchant K, Brooks LM, Apheart KL, Topol EJ. Potential value of platelet GPIIb/IIIa antagonist for treating heparin-induced thrombocytopenia (HIT) Journal of the American College of Cardiology. 27: 316. DOI: 10.1016/S0735-1097(96)82165-6 |
0.334 |
|
| 1995 |
Caple JF, Kottke-Marchant K, Miller ML. The Effect of a Heparin Removal Filter on Platelet Aggregation Studies in Heparin-Induced Thrombocytopenia American Journal of Clinical Pathology. 103: 745-747. PMID 7785661 DOI: 10.1093/Ajcp/103.6.745 |
0.343 |
|
| 1995 |
Tcheng JE, Harrington RA, Kottke-Marchant K, Kleiman NS, Ellis SG, Kereiakes DJ, Mick MJ, Navetta FI, Smith JE, Worley SJ, Miller JA, Joseph DM, Sigmon KN, Kitt MM, Du Mée CP, et al. Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention Circulation. 91: 2151-2157. PMID 7697843 DOI: 10.1161/01.Cir.91.8.2151 |
0.337 |
|
| 1995 |
Harrington RA, Kleiman NS, Kottke-Marchant K, Lincoff AM, Tcheng JE, Sigmon KN, Joseph D, Rios G, Trainor K, Rose D, Greenberg CS, Kitt MM, Topol EJ, Califf RM. Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention American Journal of Cardiology. 76: 1222-1227. PMID 7503000 DOI: 10.1016/S0002-9149(99)80345-2 |
0.34 |
|
| 1994 |
Nicolini FA, Lee P, Rios G, Kottke-Marchant K, Topol EJ. Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis. Circulation. 89: 1802-1809. PMID 8149546 DOI: 10.1161/01.Cir.89.4.1802 |
0.328 |
|
| 1992 |
Danilich MJ, Kottke-Marchant K, Anderson JM, Marchant RE. The immobilization of glucose oxidase onto radio-frequency plasma-modified poly(etherurethaneurea). Journal of Biomaterials Science. Polymer Edition. 3: 195-216. PMID 1610731 DOI: 10.1163/156856292X00123 |
0.598 |
|
| 1989 |
Kottke-Marchant K, Anderson JM, Umemura Y, Marchant RE. Effect of albumin coating on the in vitro blood compatibility of Dacron® arterial prostheses Biomaterials. 10: 147-155. PMID 2524222 DOI: 10.1016/0142-9612(89)90017-3 |
0.667 |
|
| 1987 |
Kottke-Marchant K, Anderson JM, Rabinovitch A. The platelet reactivity of vascular graft prostheses: an in vitro model to test the effect of preclotting. Biomaterials. 7: 441-8. PMID 2947640 DOI: 10.1016/0142-9612(86)90032-3 |
0.532 |
|
| 1985 |
Kottke-Marchant K, Anderson JM, Rabinovitch A, Huskey RA, Herzig R. The Effect of Heparin vs. Citrate on the Interaction of Platelets with Vascular Graft Materials Thrombosis and Haemostasis. 54: 842-848. DOI: 10.1055/S-0038-1660145 |
0.544 |
|
| Show low-probability matches. |